Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Loricrin affects skin immune function and homeostasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

TPA is about 50 times more effective at promoting tumors than MZ.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Wasabi leaf extract affects gene expression in skin cells.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A new mouse model for vitiligo helps study immune responses and potential treatments.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.